Review: could Diabetes cause Lobular capillary hemangioma?
We study 89,314 people who have Diabetes from FDA and social media. Find out below who they are, other conditions they have and drugs they take.
Stay connected: join a mobile support group for people who have Diabetes and Lobular capillary hemangioma >>>
Diabetes (latest reports from 387,161 patients) can be treated by Metformin Hydrochloride, Metformin, Lantus, Glipizide, Actos, Glyburide.
Lobular capillary hemangioma
Lobular capillary hemangioma (a benign vascular tumour of the skin or mucous membranes) (latest reports from 1,485 patients) has been reported by people with osteoporosis, breast cancer, acne, osteopenia, rheumatoid arthritis.
On Aug, 20, 2014: 89,302 people who have diabetes are studied. Among them, 1 (0.00%) has Lobular Capillary Hemangioma. They amount to 0.07% of all the 1,485 people who have Lobular Capillary Hemangioma on eHealthMe.
Gender of people who have diabetes and experienced Lobular capillary hemangioma * :
|Lobular capillary hemangioma||100.00%||0.00% |
Age of people who have diabetes and experienced Lobular capillary hemangioma * :
|Lobular capillary hemangioma||0.00||0.00||0.00||0.00||0.00||0.00||0.00||0.00 |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Pain (1 people, 100.00%)
- Musculoskeletal pain (1 people, 100.00%)
- Thyroid disorder (1 people, 100.00%)
Most common drugs used by these people * :
- Feldene (1 people, 100.00%)
- Glucophage (1 people, 100.00%)
- Lortab (1 people, 100.00%)
- Synthroid (1 people, 100.00%)
- Premarin (1 people, 100.00%)
- Lexapro (1 people, 100.00%)
- Tenoretic 50 (1 people, 100.00%)
- Seroquel (1 people, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
Get connected! Join a mobile support group:
- group for people who have Lobular Capillary Hemangioma and Diabetes
- group for people who have Diabetes
- group for people who have Lobular Capillary Hemangioma
Comments from related studies:
From this study (2 days ago):
Red, rough spot developed shortly after started bydureon. Biopsy 6 months later shows cancer. More spots appeared at 9 months and more in last month. Any other reports of skin cancer related to this drug?
From this study (1 week ago):
12 hrs after lantus, bs is going up. Also noted increased overall bs as lantus dose increased
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Diabetes, Lobular capillary hemangioma
More reviews for: Diabetes, Lobular capillary hemangioma
Common treatments for Diabetes and their efficacy:
Could your drug cause it?
Studies of common Diabetes symptoms:
- Heart Attack in Diabetes (12,569 reports)
- Blood Glucose Increased in Diabetes (8,159 reports)
- Cardiac Failure Congestive in Diabetes (7,928 reports)
- Cerebrovascular Accident in Diabetes (6,205 reports)
- Death Of Spouse in Diabetes (4,495 reports)
- Nausea in Diabetes (3,909 reports)
- Breathing Difficulty in Diabetes (3,646 reports)
- Cad in Diabetes (3,605 reports)
- Cardiac Disorder in Diabetes (3,464 reports)
- Htn in Diabetes (3,380 reports)
Lobular Capillary Hemangioma related symptom studies:
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.